About
My academic journey began at the University of Bath, where I earned a degree in Molecular and Cellular Biology. Following this, I joined the University of Oxford as a research assistant, working on the development of monoclonal antibodies targeting cancer cell markers. After two years, I transitioned to the Sir William Dunn School of Pathology to work with Professor Christoph Tang, contributing to vaccine development against Neisseria meningitidis, a human-specific pathogen. This research has remained a central focus of mine, including recent pre-clinical vaccine development in collaboration with the Serum Institute of India.
Building on this foundation, I completed my PhD at Oxford, investigating the genetic and bacterial factors that influence an individual’s susceptibility to invasive meningococcal disease and the distinction between invasive infection and asymptomatic carriage. In my postdoctoral work, I pioneered the development of novel monoclonal antibody therapeutics targeting Neisseria gonorrhoeae, a closely related, antibiotic-resistant pathogen.
In July 2024, I was appointed Lecturer in Microbial Pathogenesis at the University of Liverpool. My current research focuses on the interactions between N. gonorrhoeae and the human complement system, as well as the advancement of novel therapeutic strategies against this challenging pathogen.